AbCellera Biologics Inc. (ABCL) Total liabilities 2020–2025
AbCellera Biologics Inc. (ABCL) total liabilities at each fiscal year-end, per SEC filings.
$390.0MFY2025 · since FY2020: $175.0M → $390.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $390.0M | +28.1% |
| FY2024 | $304.5M | -9.3% |
| FY2023 | $335.8M | +9.1% |
| FY2022 | $307.6M | +5.1% |
| FY2021 | $292.8M | +67.3% |
| FY2020 | $175.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice